Skip to main content

Physician Search

 


Displaying 1 - 1 of 1

ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma

Sarcoma

This is a multicenter open-label, randomized, non-comparative, parallel cohort pivotal study of treatment with envafolimab (cohort A and C) or envafolimab combined with ipilimumab (cohort B and D) in patients with locally advanced, unresectable or metastatic undifferentiated pleomorphic sarcoma (UPS) / myxofibrosarcoma (MFS) who have progressed on one or two lines of chemotherapy.
Sarcoma
II
Keedy, Vicki
NCT04480502
VICCSAR2076